Since the two groups of patients (i.e., patients with cirrhosis and patients with HCC) showed significant differences regarding demographic and biochemical features, we performed a multivariate logistic regression analysis to test whether the observed differences may impact on the performance of AFP, PIVKA-II and GPC-3 (Table 4). The gene discussed is AFP; the disease is hepatocellular carcinoma.